Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering human peritoneum in vitro: A novel microfluidic platform for modeling peritoneal physiology and pathophysiology.

Bioengineering & translational medicine·2026
Same author

CRISPR-Cas9-mediated knock-in of cytomegalovirus US2 provides an alternative strategy for generating hypoimmunogenic hiPSC lines.

Scientific reports·2026
Same author

Deep-sequencing-guided library screening and profiling of AAV capsids in the primate retina.

Molecular therapy. Advances·2026
Same author

Generation of a STRAIGHT-IN Dual AAVS1 hiPSC line with orthogonal landing pads for versatile DNA payload integration.

Stem cell research·2026
Same author

Cardiomyopathy phenotypes caused by a heterozygous MYBPC3 mutation revealed in different hiPSC cardiac models.

Experimental cell research·2026
Same author

Deciphering and targeting the pathogenic circuit of nonlytic hepatitis E virus infection using macrophage-augmented organoids.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Sep 24, 2025

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

10.1K

Microphysiological stem cell models of the human heart.

Ulgu Arslan1, Alessia Moruzzi2,3, Joanna Nowacka4

  • 1Department of Anatomy and Embryology, Leiden University Medical Centre, Leiden, the Netherlands.

Materials Today. Bio
|May 6, 2022
PubMed
Summary

Human pluripotent stem cells (hPSCs) offer superior human heart models over animal studies. Advanced 3D models using hPSC-derived cells overcome limitations of simple cultures for studying heart disease and drug responses.

Keywords:
Cardiac microtissueCardiomyocyte maturationEngineered heart tissueFunctional readoutHeart-on-chipHuman induced pluripotent stem cellsMulticellular cell diseases and drug efficacy platformStructural readout

More Related Videos

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
10:41

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Published on: January 23, 2021

7.9K
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

6.8K

Related Experiment Videos

Last Updated: Sep 24, 2025

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

10.1K
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
10:41

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Published on: January 23, 2021

7.9K
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

6.8K

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Pharmacology

Background:

  • Human pluripotent stem cells (hPSCs) are increasingly utilized for modeling human heart diseases and drug responses due to their superior ability to recapitulate human cardiac function compared to animal models.
  • Traditional monolayer cultures of hPSC-derived cardiomyocytes exhibit limitations in fully capturing complex cardiac physiology and disease states.

Purpose of the Study:

  • To review advanced 3D multi-cell-type models that overcome the shortcomings of simple hPSC-derived cardiomyocyte cultures.
  • To discuss tailored readouts and sensors for monitoring tissue and cellular physiology in these complex models.
  • To explore the perspectives for implementing these advanced models in both academic research and industrial drug development.

Main Methods:

  • Review of existing literature on 3D multi-cell-type models derived from human pluripotent stem cells.
  • Analysis of various ex vivo and in situ monitoring techniques and sensor technologies for physiological measurements.
  • Discussion of implementation strategies and future directions for advanced cardiac modeling.

Main Results:

  • 3D multi-cell-type models offer enhanced recapitulation of human cardiac (dys-)function compared to 2D cultures.
  • Development of sophisticated monitoring tools and sensors is crucial for effective physiological assessment in these models.
  • These advanced models hold significant promise for improving the accuracy and efficiency of heart disease research and drug discovery.

Conclusions:

  • Advanced 3D models utilizing human pluripotent stem cells represent a significant advancement in studying heart disease and drug responses.
  • Integration of tailored readouts and sensors is key to unlocking the full potential of these complex cardiac models.
  • These innovative approaches are poised to accelerate progress in cardiovascular research and pharmaceutical development.